Back to Search Start Over

Polygenic risk scores identify heterogeneity in asthma and chronic obstructive pulmonary disease.

Authors :
Moll M
Sordillo JE
Ghosh AJ
Hayden LP
McDermott G
McGeachie MJ
Dahlin A
Tiwari A
Manmadkar MG
Abston ED
Pavuluri C
Saferali A
Begum S
Ziniti JP
Gulsvik A
Bakke PS
Aschard H
Iribarren C
Hersh CP
Sparks JA
Hobbs BD
Lasky-Su JA
Silverman EK
Weiss ST
Wu AC
Cho MH
Source :
The Journal of allergy and clinical immunology [J Allergy Clin Immunol] 2023 Dec; Vol. 152 (6), pp. 1423-1432. Date of Electronic Publication: 2023 Aug 16.
Publication Year :
2023

Abstract

Background: Asthma and chronic obstructive pulmonary disease (COPD) have distinct and overlapping genetic and clinical features.<br />Objective: We sought to test the hypothesis that polygenic risk scores (PRSs) for asthma (PRS <subscript>Asthma</subscript> ) and spirometry (FEV <subscript>1</subscript> and FEV <subscript>1</subscript> /forced vital capacity; PRS <subscript>spiro</subscript> ) would demonstrate differential associations with asthma, COPD, and asthma-COPD overlap (ACO).<br />Methods: We developed and tested 2 asthma PRSs and applied the higher performing PRS <subscript>Asthma</subscript> and a previously published PRS <subscript>spiro</subscript> to research (Genetic Epidemiology of COPD study and Childhood Asthma Management Program, with spirometry) and electronic health record-based (Mass General Brigham Biobank and Genetic Epidemiology Research on Adult Health and Aging [GERA]) studies. We assessed the association of PRSs with COPD and asthma using modified random-effects and binary-effects meta-analyses, and ACO and asthma exacerbations in specific cohorts. Models were adjusted for confounders and genetic ancestry.<br />Results: In meta-analyses of 102,477 participants, the PRS <subscript>Asthma</subscript> (odds ratio [OR] per SD, 1.16 [95% CI, 1.14-1.19]) and PRS <subscript>spiro</subscript> (OR per SD, 1.19 [95% CI, 1.17-1.22]) both predicted asthma, whereas the PRS <subscript>spiro</subscript> predicted COPD (OR per SD, 1.25 [95% CI, 1.21-1.30]). However, results differed by cohort. The PRS <subscript>spiro</subscript> was not associated with COPD in GERA and Mass General Brigham Biobank. In the Genetic Epidemiology of COPD study, the PRS <subscript>Asthma</subscript> (OR per SD: Whites, 1.3; African Americans, 1.2) and PRS <subscript>spiro</subscript> (OR per SD: Whites, 2.2; African Americans, 1.6) were both associated with ACO. In GERA, the PRS <subscript>Asthma</subscript> was associated with asthma exacerbations (OR, 1.18) in Whites; the PRS <subscript>spiro</subscript> was associated with asthma exacerbations in White, LatinX, and East Asian participants.<br />Conclusions: PRSs for asthma and spirometry are both associated with ACO and asthma exacerbations. Genetic prediction performance differs in research versus electronic health record-based cohorts.<br /> (Published by Elsevier Inc.)

Details

Language :
English
ISSN :
1097-6825
Volume :
152
Issue :
6
Database :
MEDLINE
Journal :
The Journal of allergy and clinical immunology
Publication Type :
Academic Journal
Accession number :
37595761
Full Text :
https://doi.org/10.1016/j.jaci.2023.08.002